Fingerprint
Dive into the research topics of 'CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS
Michael Peter Diamond, V Limmroth, F Barkhof, N Desem, G Tachas
Research output: Contribution to journal › Article › peer-review
43
Scopus
citations